4/8/2025China Approves Hansoh's Ibrexafungerp for Vaginal Yeast Infections

4/8/2025NIH Ban Disrupts Some Chinese Genetics Research, But Broader Impact Se...

4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...

4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses

4/7/2025China Receives 2.6 Million ADR Reports in 2024, Severe Cases Make Up 1...

4/7/2025Boehringer Ingelheim Highlights Long-Term Commitment to China, Focuses...

4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...

4/5/2025Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...

4/5/2025Sanofi and Cathay Capital Launch CNY 2B Healthcare Innovation Fund in ...

4/5/2025Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy

4/5/2025China and WHO Collaborate on Quality Management Training to Boost Vacc...

4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...

4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations

4/5/2025Recent Executive Moves

4/5/2025China Biopharma Licensing Tracker, Q1 2025 (MC)

4/5/2025China Biopharma Financing Tracker, Q1 2025 (MC)

4/5/2025Analysis of China-to-West Pharmaceutical Licensing Deals in 2024 (Natu...

4/1/2025China's Pharma Industry Shows Signs of Recovery After Economic Downtur...

4/1/2025China Accelerates Brain Chip Trials After Initial Success

4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy

4/1/2025Vivace Thera Raises $35M in Series D Financing

4/1/2025Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China

3/31/2025CDE Solicits Comments on the Draft Technical Specification of ICH M11:...

3/31/2025Vcare PharmaTech Secures Series C+ Financing and Advances Clinical Pip...

3/31/2025BMS's Opdivo and Yervoy Combio Approved in China

3/31/2025Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...

3/31/2025Roche's Ocrevus Receives Chinese Approval for MS

3/31/2025Bio-Thera and Dr. Reddy's Execute Commercialization Deal for BAT2206 a...

3/31/2025Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib

3/28/2025Eisai to Divest China Rights for Pariet® to Peak Pharma

Page:32/790 Total number of articles:23693: [First][<<] [30] [31] [32] [33] [34] [>>] [End]